6330 Nancy Ridge Drive, Suite 106
San Diego, 92121
United States of America, California
Toll free: (866) 623-8105
Phone: (858) 623-8105
Fax: (858) 623-8109
InVivoScribe Technologies is a debt-free & profitable, privately-held biotechnology company located in San Diego, California. The focus of the company is to provide reliable cutting-edge tools for molecular diagnostics, hematopathology, and complementary DNA synthesis using our proprietary technologies.
The company was founded in 1995 based upon InVivoScribe’s patented in vivo cDNA synthesis technologies. These technologies convert unstable cellular messenger RNA into stable complementary DNA within the living cells and tissues – enhancing the quality and reproducibility of cDNA products and eliminating difficulties and bias associated with RNA extraction and in vitro methods for cDNA synthesis.
InVivoScribe also offers a comprehensive selection of standardized and validated PCR-based gene rearrangement, chromosome translocation, and gene mutation testing products and controls to the hematopathology community.
Customers include many of the world’s leading pharmaceutical and biotechnology companies, medical centers, cancer research centers, reference laboratories and molecular diagnostic testing centers. Our products are used to identify, classify and monitor leukemias, lymphomas and other lymphoproliferative disease.
As a CRO InVivoScribe provides tests and services to assist in the development of pharmaceutical agents and devices. We also produce OEM Reagents dedicated for use with specific analytical platforms.
InVivoScribe’s gene rearrangement testing products are covered by exclusive-licensed patents.